Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
16.13
+0.07 (0.44%)
Apr 30, 2026, 11:29 AM CST
-35.76% (1Y)
| Market Cap | 2.68B |
| Revenue (ttm) | 418.18M |
| Net Income (ttm) | 55.16M |
| Shares Out | 166.80M |
| EPS (ttm) | 0.33 |
| PE Ratio | 48.72 |
| Forward PE | n/a |
| Dividend | 0.20 (1.27%) |
| Ex-Dividend Date | Jul 10, 2025 |
| Volume | 2,460,803 |
| Average Volume | 3,815,648 |
| Open | 16.04 |
| Previous Close | 16.06 |
| Day's Range | 15.99 - 16.41 |
| 52-Week Range | 14.46 - 31.13 |
| Beta | 0.53 |
| RSI | 37.22 |
| Earnings Date | Apr 23, 2026 |